https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7607 Wed 11 Apr 2018 15:15:09 AEST ]]> Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15188 Wed 11 Apr 2018 11:51:25 AEST ]]> Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16769 Wed 11 Apr 2018 09:29:25 AEST ]]> Moderators of Exercise Effects on Cancer-related Fatigue: A Meta-analysis of Individual Patient Data. https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40943 Wed 10 May 2023 10:32:14 AEST ]]> A gender-sensitised weight-loss and healthy living program for men with overweight and obesity in Australian Football League settings (Aussie-FIT): a pilot randomised controlled trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37187 2), middle-aged (35-65 years old) men. Participants were recruited in May 2018, and the intervention took place between June and December 2018. The intervention involved 12 weekly 90-min face-to-face sessions, incorporating physical activity, nutrition, and behaviour change information and practical activities delivered by coaches at 2 clubs. Data were collected at baseline and immediately postintervention. For trial feasibility purposes, 6-month follow-ups were completed. Outcomes were differences in weight loss (primary outcome) and recruitment and retention rates, self-reported measures (for example, psychological well-being), device-measured physical activity, waist size, and blood pressure at 3 months. Within 3 days of advertising at each club, 426 men registered interest; 306 (72%) were eligible. Men were selected on a first-come first-served basis (n = 130; M age = 45.8, SD = 8; M BMI = 34.48 kg/m2 SD = 4.87) and randomised by a blinded researcher. Trial retention was 86% and 63% at 3- and 6-month follow-ups (respectively). No adverse events were reported. At 3 months, mean difference in weight between groups, adjusted for baseline weight and group, was 3.3 kg (95% CI 1.9, 4.8) in favour of the intervention group (p < 0.001). The intervention group's moderate-to-vigorous physical activity (MVPA) was higher than the control group by 8.54 min/day (95% CI 1.37, 15.71, p = 0.02). MVPA among men attracted to Aussie-FIT was high at baseline (intervention arm 35.61 min/day, control arm 38.38 min/day), which may have limited the scope for improvement. Conclusion: Aussie-FIT was feasible to deliver; participants increased physical activity, decreased weight, and reported improvements in other outcomes. Issues with retention were a limitation of this trial. In a future, fully powered randomised controlled trial (RCT), retention could be improved by conducting assessments outside of holiday seasons.]]> Wed 07 Apr 2021 20:21:06 AEST ]]> Cost-effectiveness analysis of supervised exercise training in men with prostate cancer previously treated with radiation therapy and androgen-deprivation therapy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38927  5 years post-diagnosis). Analysis was undertaken for the 6-month supervised exercise portion of the intervention, which involved 100 men aged between 62 and 85 years, 50 in each arm. The primary outcome was cost per quality-adjusted life-years (QALYs). Results: A 6-month supervised exercise intervention for PCa survivors resulted in an incremental cost-effectiveness ratio of AU$64,235 (2018 AUD) at an incremental cost of AU$546 per person and a QALY gain of 0.0085. At a willingness-to-pay of AU$50,000, the probability that the intervention is cost-effective was 41%. Sensitivity analysis showed that maintenance of benefits via a 6-month home-based intervention, immediately following the supervised intervention, lowered the cost per QALY gained to AU$32,051. Discussion: This is the first cost-effectiveness analysis of exercise for PCa survivors. The intervention was effective, but unlikely to be cost-effective at the generally accepted willingness-to-pay of AU$50,000 per QALY. It is likely that evidence to support cost savings from post-intervention outcomes would reveal greater benefits and contribute to a more comprehensive cost-effectiveness analysis. Future RCTs should incorporate longer follow-up durations and collection of data to support modelling to capture future health benefits. Measures of quality of life or utility more sensitive to the impact of physical activity would also improve future economic evaluations.]]> Tue 08 Mar 2022 11:43:17 AEDT ]]> Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44701 Thu 20 Oct 2022 15:58:29 AEDT ]]> Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12309 Sat 24 Mar 2018 08:11:38 AEDT ]]> A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17463 5 yr postdiagnosis on physical functioning.Design, setting, and participants. Between 2010 and 2011, 100 long-term PCa survivors from Trans-Tasman Radiation Oncology Group 03.04 Randomised Androgen Deprivation and Radiotherapy previously treated with androgen-deprivation therapy and radiation therapy were randomly assigned to 6 mo of supervised exercise followed by 6 mo of a home-based maintenance programme (n = 50) or printed educational material about physical activity (n = 50) for 12 mo across 13 university-affiliated exercise clinics in Australia and New Zealand. Intervention: Supervised resistance and aerobic exercise or printed educational material about physical activity. Outcome measurements and statistical analysis: The primary end point was a 400-m walk as a measure of cardiovascular fitness. Secondary end points were physical function, patient-reported outcomes, muscle strength, body composition, and biomarkers. Analysis of covariance was used to compare outcomes for groups at 6 and 12 mo adjusted for baseline values. Results and limitations: Participants undergoing supervised exercise showed improvement in cardiorespiratory fitness performance at 6 mo (−19 s [p = 0.029]) and 12 mo (−13 s [p = 0.028]) and better lower-body physical function across the 12-mo period (p < 0.01). Supervised exercise also improved self-reported physical functioning at 6 (p = .006) and 12 mo (p = 0.002), appendicular skeletal muscle at 6 mo (p = 0.019), and objective measures of muscle strength at 6 and 12 mo (p < 0.050). Limitations included the restricted number of participants undertaking body composition assessment, no blinding to group assignment for physical functioning measures, and inclusion of well-functioning individuals. Conclusions: Supervised exercise training in long-term PCa survivors is more effective than physical activity educational material for increasing cardiorespiratory fitness, physical function, muscle strength, and self-reported physical functioning at 6 mo. Importantly, these benefits were maintained in the long term with a home-based programme with follow-up at 12 mo. Clinical trial registry: The effect of an exercise intervention on cardiovascular and metabolic risk factors in prostate cancer patients from the RADAR study, ACTRN: ACTRN12609000729224.]]> Sat 24 Mar 2018 08:04:06 AEDT ]]> Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20738 Sat 24 Mar 2018 08:00:27 AEDT ]]> Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20479 Sat 24 Mar 2018 07:59:08 AEDT ]]> Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17874 Sat 24 Mar 2018 07:56:44 AEDT ]]> Maximal exercise testing of men with prostate cancer being treated with androgen deprivation therapy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21252 3 months (chronic). Results: Of these men, 85% were able to meet the criteria for the attainment of V·O2max, whereas three positive tests (3.2%) were observed. The three participants who recorded a positive stress test underwent further medical examination and were subsequently cleared of clinically significant cardiovascular disease. Apart from the relatively low V·O2max (24.7 ± 6.0 mL·kg⁻¹·min⁻¹, 10th–15th percentile), compared with normative data in healthy age-matched controls, the cardiovascular response to exercise was similar in this cancer population. Moreover, treatment duration did not seem to influence cardiovascular responses to exercise. This early evidence suggests that risk of adverse events during maximal exercise testing is relatively low in this population and certainly no higher than that in ages-matched, apparently healthy individuals. Conclusions: Maximal exercise testing was demonstrated to be feasible and safe, providing a direct assessment of V·O2max. The relatively low number of positive tests in this study suggests that the risk of adverse events is relatively low in this population and certainly no higher than that in age-matched, apparently healthy individuals.]]> Sat 24 Mar 2018 07:54:34 AEDT ]]> Detecting deficits in change of direction performance using the preplanned multidirectional Australian football league agility test https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:21111 t-tests (p = 0.05) were used to examine differences between dominant and nondominant trials. Independent t-tests (p- = 0.05) were used to identify differences between left and right leg dominant groups. The current version of the AFL agility test appropriately examined ~61% of footballers in this cohort. The remaining ~39% produced significantly faster times during the alternate version (0.63-0.82 seconds; p = 0.001). All footballers demonstrated a performance deficit of 5-10% between limbs (~0.72 seconds; p = 0.001). Limb dominance (directional preference) was evident for all footballers. Change of direction capabilities should therefore be examined bilaterally to eliminate bias toward athletes with particular leg dominance profiles and to provide a limb deficit measure for enhanced athletic profiling outcomes.]]> Sat 24 Mar 2018 07:54:00 AEDT ]]> The effect, moderators, and mediators of resistance and aerobic exercise on health-related quality of life in older long-term survivors of prostate cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28140 Sat 24 Mar 2018 07:36:38 AEDT ]]> Exercise therapy for sexual dysfunction after prostate cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:28842 Sat 24 Mar 2018 07:33:18 AEDT ]]> Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26742 Sat 24 Mar 2018 07:24:48 AEDT ]]> The Aussie-FIT process evaluation: feasibility and acceptability of a weight loss intervention for men, delivered in Australian Football League settings https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44544 Mon 17 Oct 2022 09:31:23 AEDT ]]> Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42994 Fri 09 Sep 2022 14:03:28 AEST ]]> Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33527 difference_in_effect = 0.13, 95%CI = 0.03;0.22) and PF (βdifference_in_effect = 0.10, 95%CI = 0.01;0.20) were significantly larger for supervised than unsupervised interventions. In conclusion, exercise, and particularly supervised exercise, effectively improves QoL and PF in patients with cancer with different demographic and clinical characteristics during and following treatment. Although effect sizes are small, there is consistent empirical evidence to support implementation of exercise as part of cancer care.]]> Fri 03 Dec 2021 10:34:03 AEDT ]]> Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34907 interaction = -1.3 s, 95% confidence interval [CI] -2.6 to 0.0), whole-body lean mass (ßinteraction = 1194 g, 95% CI 234 to 2153) and ASM mass (ßinteraction = 562 g, 95% CI 49 to 1075), and approached significance for fat mass (ßinteraction = -1107 g, 95% CI -2346 to 132), with greater benefits for men previously on long-term ADT. At 6 months, the intervention effects on chair rise time -1.5 s (95% CI -2.5 to -0.5), whole-body lean mass 824 g (95% CI 8 to 1640), ASM mass 709 g (95% CI 260 to 1158), and fat mass -1377 g (95% CI -2156 to -598) were significant for men previously on long-term ADT, but not for men on short-term ADT. At 12 months, the intervention effects for men on long-term ADT remained significant for the chair rise, with improved performance (-2.0 s, 95% CI -3.0 to -1.0) and increased ASM (537 g, 95% CI 153 to 921). Time on ADT did not moderate the exercise effects on muscle strength, nor did time since ADT cessation moderate any intervention effects. Similarly, testosterone and baseline values of the outcome had negligible moderator effects. Conclusions: Men with PCa previously treated long-term with ADT respond more favourably to exercise in terms of lower body muscle performance and body composition (lean and fat mass, and ASM) than those with short-term ADT exposure. As a result, men who were formerly on long-term androgen suppression regimens should be especially prescribed exercise medicine interventions to alleviate residual treatment-related adverse effects.]]> Fri 01 Apr 2022 09:25:19 AEDT ]]>